BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, Chen ZS, Ye W, Zhang D. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects. Drug Resist Updat 2022;64:100849. [PMID: 35842983 DOI: 10.1016/j.drup.2022.100849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Isadora Boni F, Noronha Ferreira N, Fernanda Rodero C, Franciane Leão A, Stringhetti Ferreira Cury B, Palmira Daflon Gremião M. Multilayered polymer coating modulates mucoadhesive and biological properties of camptothecin-loaded lipid nanocapsules. Int J Pharm 2023;635:122792. [PMID: 36863543 DOI: 10.1016/j.ijpharm.2023.122792] [Reference Citation Analysis]
2 Laumont CM, Nelson BH. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Cancer Cell 2023;41:466-89. [PMID: 36917951 DOI: 10.1016/j.ccell.2023.02.017] [Reference Citation Analysis]
3 Zeng K, Xie W, Wang C, Wang S, Liu W, Su Y, Lin L, Zou R, Sun G, Zhou B, Wang M, Luan R, Bai Y, Huo Y, Kato S, Zhong X, Zhao Y. USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell Death Dis 2023;14:194. [PMID: 36906615 DOI: 10.1038/s41419-023-05699-y] [Reference Citation Analysis]
4 Jiang Z, Zhou J, Li L, Liao S, He J, Zhou S, Zhou Y. Pericytes in the tumor microenvironment. Cancer Lett 2023;556:216074. [PMID: 36682706 DOI: 10.1016/j.canlet.2023.216074] [Reference Citation Analysis]
5 Dzobo K, Senthebane DA, Dandara C. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited. Cancers (Basel) 2023;15. [PMID: 36672326 DOI: 10.3390/cancers15020376] [Reference Citation Analysis]
6 Li W, Zhao Y, Wang Y, He Z, Zhang L, Yuan B, Li C, Luo Z, Gao B, Yan M. Deciphering the sequential changes of monocytes/macrophages in the progression of IDD with longitudinal approach using single-cell transcriptome. Front Immunol 2023;14:1090637. [PMID: 36817437 DOI: 10.3389/fimmu.2023.1090637] [Reference Citation Analysis]
7 Zhang J, Lu T, Lu S, Ma S, Han D, Zhang K, Xu C, Liu S, Gan L, Wu X, Yang F, Wen W, Qin W. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues. Comput Struct Biotechnol J 2023;21:665-76. [PMID: 36659929 DOI: 10.1016/j.csbj.2022.12.049] [Reference Citation Analysis]
8 Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X. The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol 2022;13:1055087. [PMID: 36582230 DOI: 10.3389/fimmu.2022.1055087] [Reference Citation Analysis]
9 Annese T, Errede M, d'Amati A, De Giorgis M, Lorusso L, Tamma R, Ribatti D. Differential P-Glycoprotein/CD31 Expression as Markers of Vascular Co-Option in Primary Central Nervous System Tumors. Diagnostics (Basel) 2022;12. [PMID: 36553127 DOI: 10.3390/diagnostics12123120] [Reference Citation Analysis]
10 wu J, Zhang L, Li W, Wang L, Li K, Shi F, Jia Q, Liao L, Shi Y, Wu S. The role of TOP2A in immunotherapy and Vasculogenic mimicry in non-small cell lung cancer and its potential mechanism.. [DOI: 10.21203/rs.3.rs-2321012/v1] [Reference Citation Analysis]
11 Mosleh-Shirazi S, Abbasi M, Moaddeli MR, Vaez A, Shafiee M, Kasaee SR, Amani AM, Hatam S. Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview. Nanotheranostics 2022;6:400-23. [PMID: 36051855 DOI: 10.7150/ntno.74613] [Reference Citation Analysis]